company background image
UG logo

United-Guardian NasdaqGM:UG Stock Report

Last Price

US$13.79

Market Cap

US$63.4m

7D

-3.3%

1Y

77.7%

Updated

08 Sep, 2024

Data

Company Financials

United-Guardian, Inc.

NasdaqGM:UG Stock Report

Market Cap: US$63.4m

UG Stock Overview

Manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

UG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

United-Guardian, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for United-Guardian
Historical stock prices
Current Share PriceUS$13.79
52 Week HighUS$15.02
52 Week LowUS$5.79
Beta0.79
11 Month Change25.94%
3 Month Change54.08%
1 Year Change77.71%
33 Year Change-6.70%
5 Year Change-27.65%
Change since IPO163.63%

Recent News & Updates

Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%

Sep 08
Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%

United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's

Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price

Jul 15
Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price

Recent updates

Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%

Sep 08
Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%

United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's

Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price

Jul 15
Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price

United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively

May 14
United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively

United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside

Feb 20

Returns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)

Feb 04
Returns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)

United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings

Dec 29
United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings

Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Nov 07
Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Jul 18
Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital

Mar 07
United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital

Why We Like The Returns At United-Guardian (NASDAQ:UG)

Nov 11
Why We Like The Returns At United-Guardian (NASDAQ:UG)

Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Oct 12
Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Buying Back Into United-Guardian, Inc.

Aug 15

United-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year

May 15
United-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year

United-Guardian: Pristine Balance Sheet, Nice Dividend, But Fully Valued

Apr 11

Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

Feb 01
Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package

May 12
We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package

Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?

Mar 15
Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?

Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?

Feb 23
Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?

Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

Feb 02
Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.

Jan 13
United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.

Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Dec 22
Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Our View On United-Guardian's (NASDAQ:UG) CEO Pay

Dec 04
Our View On United-Guardian's (NASDAQ:UG) CEO Pay

United-Guardian cuts dividend by ~14%

Nov 20

United-Guardian reports Q3 results

Nov 10

Shareholder Returns

UGUS Personal ProductsUS Market
7D-3.3%-2.2%-4.4%
1Y77.7%-18.4%19.1%

Return vs Industry: UG exceeded the US Personal Products industry which returned -18.4% over the past year.

Return vs Market: UG exceeded the US Market which returned 19.1% over the past year.

Price Volatility

Is UG's price volatile compared to industry and market?
UG volatility
UG Average Weekly Movement7.5%
Personal Products Industry Average Movement9.0%
Market Average Movement6.3%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.1%

Stable Share Price: UG's share price has been volatile over the past 3 months.

Volatility Over Time: UG's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194224n/awww.u-g.com

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company’s pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.

United-Guardian, Inc. Fundamentals Summary

How do United-Guardian's earnings and revenue compare to its market cap?
UG fundamental statistics
Market capUS$63.36m
Earnings (TTM)US$3.25m
Revenue (TTM)US$12.31m

19.5x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UG income statement (TTM)
RevenueUS$12.31m
Cost of RevenueUS$6.07m
Gross ProfitUS$6.24m
Other ExpensesUS$2.99m
EarningsUS$3.25m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.71
Gross Margin50.66%
Net Profit Margin26.37%
Debt/Equity Ratio0%

How did UG perform over the long term?

See historical performance and comparison

Dividends

4.4%

Current Dividend Yield

85%

Payout Ratio